| Christopher Magalhaes, | |
|
4995 S County Trl, Charlestown, RI 02813-3182 | |
| (401) 364-6300 | |
| Not Available |
| Full Name | Christopher Magalhaes |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 4995 S County Trl, Charlestown, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215596481 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | DEN03455 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Magalhaes, 9 Jordan Ln, East Freetown, MA 02717-1036 Ph: (774) 488-9204 | Christopher Magalhaes, 4995 S County Trl, Charlestown, RI 02813-3182 Ph: (401) 364-6300 |
News Archive
Results from the TRAPID-AMI clinical study have been published online by the Annals of Emergency Medicine, confirming a novel approach for a more rapid diagnosis of heart attack in patients with acute chest pain.
A study led by researchers at the Joslin Diabetes Center suggests that adding the amino acid leucine to their diets may help those with pre-diabetes or metabolic syndrome.
Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received approval today from the United States Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Levonorgestrel Tablets, 0.75 mg for over-the-counter use in women ages 17 and above, as well as for prescription use in women under the age of 17.
A new vaccine designed to stimulate an immune response against a cancer-causing human papillomavirus (HPV-16) can eliminate chronic infection by the virus and may cause regression of precancerous genital lesions in women who receive the vaccine.
A pre-exposure prophylaxis (PrEP) regimen containing an investigational long-acting form of the HIV drug cabotegravir injected once every 8 weeks was more effective than daily oral Truvada at preventing HIV acquisition among cisgender men who have sex with men and transgender women who have sex with men in a clinical trial sponsored by the National Institutes of Health.
› Verified 6 days ago
Dr. Mia Baker, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 4995 S County Trl, Charlestown, RI 02813 Phone: 401-364-6300 | |
Richard Dana Walsh, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 4995 S County Trl, Charlestown, RI 02813 Phone: 401-364-6300 Fax: 401-364-9190 | |
Dr. Nicolette Justine Angioli, DMD Dentist Medicare: Medicare Enrolled Practice Location: 4995 S County Trl, Charlestown, RI 02813 Phone: 518-231-9657 | |
Marie Christine Benoit, D.M.D. Dentist Medicare: Medicare Enrolled Practice Location: 4995 S County Trl, Charlestown, RI 02813 Phone: 401-364-6300 Fax: 401-364-9190 | |
Bruce D Gouin, D.M.D. Dentist Medicare: Medicare Enrolled Practice Location: 4995 S County Trl, Charlestown, RI 02813 Phone: 401-364-6300 Fax: 401-364-9190 | |
Brendan C. Gouin, D.M.D. Dentist Medicare: Medicare Enrolled Practice Location: 4995 S County Trl, Charlestown, RI 02813 Phone: 401-364-6300 Fax: 401-364-9190 |